Tanner Pharma Group
Modern Slavery Statement
Purpose and Scope
Tanner Pharma Group (“Tanner”), including but not limited to Tanner Pharma UK Limited and TannerLAC UK Limited (both United Kingdom registered companies), recognises that slavery and human trafficking can occur in many forms. We have taken, and will continue to take, a number of steps to ensure that modern slavery is not taking place anywhere in our own business or in any of our supply chains. We are committed to acting ethically, with integrity and transparency in all business dealings including complying with the requirements of the UK Modern Slavery Act 2015. Tanner recognises that all businesses have an obligation to prevent slavery and human trafficking and we require an equal commitment from all our suppliers. Every company must do its share to eradicate this modern-day scourge.
No Involuntary Labour
Suppliers must not use or facilitate any type of involuntary labour, including forced, compulsory, indentured, bonded, slave or human trafficked labour. Suppliers must not traffic individuals or groups for the purpose of labour exploitation. All employees must be voluntary and should be free to leave upon reasonable notice.
Tanner does not accept any child labour or any practice that inhibits the development of children. The term “child” refers to any person under the age of 16 (or according to the applicable local laws) or under the minimum age of employment in any particular country. Employees under the age of 18 should not perform hazardous work and such individuals must provide documented informed consent.
Fair Wage & Working Hours
Suppliers must provide fair remuneration, reasonable working hours, leave periods and public holidays in compliance with all applicable local wages, hour laws and regulations. Any maximum working hours should not be exceeded. Overtime should be voluntary and workers must receive adequate compensation for any overtime worked.
About Tanner Pharma Group
For over 16 years, Tanner Pharma Group has partnered with biopharmaceutical companies to provide turn-key commercialization solutions to increase patient access to medicines around the world. By partnering with Tanner Pharma, biotech and pharma companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.
Tanner Pharma believes that access to medicines should have no borders and measures its value as a company based on the lives it helps to improve. With an unparalleled blend of local market knowledge, international supply chain expertise across more than 130 countries, and high regulatory compliance and quality standards, it provides tailored solutions to biopharmaceutical companies outside their core markets of focus.
Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.
For more information about Tanner Pharma Group, please visit www.tannerpharma.com.